A value-based fund that seeks to balance long-term growth with income.
Is this fund right for you?
- You’re looking to preserve your investment while still allowing it to grow.
- You want to invest in high-quality govenment bonds and common and preferred stocks from market-leading companies.
- You're comfortable with a low to moderate level of risk.
Risk Rating
How is the fund invested?
(as of August 31, 2025)
Asset allocation (%)
|
Name |
Percent |
|
Canadian Equity |
42.1 |
|
Domestic Bonds |
27.5 |
|
US Equity |
19.7 |
|
International Equity |
7.9 |
|
Cash and Equivalents |
2.7 |
|
Other |
0.1 |
Geographic allocation (%)
|
Name |
Percent |
|
Canada |
72.4 |
|
United States |
19.8 |
|
Ireland |
5.3 |
|
United Kingdom |
2.6 |
|
Other |
-0.1 |
Sector allocation (%)
|
Name |
Percent |
|
Fixed Income |
27.5 |
|
Financial Services |
21.0 |
|
Technology |
9.3 |
|
Healthcare |
7.0 |
|
Industrial Services |
6.4 |
|
Consumer Goods |
5.9 |
|
Energy |
4.1 |
|
Telecommunications |
4.0 |
|
Real Estate |
3.4 |
|
Other |
11.4 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of August 31, 2025)
Top holdings |
% |
Brookfield Corp Cl A |
4.3 |
Royal Bank of Canada |
4.0 |
Icon PLC |
2.8 |
Telus Corp |
2.7 |
Ashtead Group PLC |
2.6 |
Aon PLC Cl A |
2.5 |
Toronto-Dominion Bank |
2.5 |
Canadian Natural Resources Ltd |
2.4 |
Fairfax Financial Holdings Ltd |
2.4 |
Canadian Pacific Kansas City Ltd |
2.1 |
Total allocation in top holdings |
28.3 |
Portfolio characteristics |
|
Standard deviation |
11.4% |
Dividend yield |
1.9% |
Yield to maturity |
4.0% |
Duration (years) |
5.7 |
Coupon |
3.9% |
Average credit rating |
A |
Understanding returns
Annual compound returns (%)
1 MO |
3 MO |
YTD |
1 YR |
{{snapShot.Return1Mth|customNumber:1}} | {{snapShot.Return3Mth|customNumber:1}} | {{snapShot.ReturnYTD|customNumber:1}} | {{snapShot.Return1Yr|customNumber:1}} |
3 YR |
5 YR |
10 YR |
INCEPTION |
{{snapShot.Return3Yr|customNumber:1}} | {{snapShot.Return5Yr|customNumber:1}} | {{snapShot.Return10Yr|customNumber:1}} | {{snapShot.ReturnInception|customNumber:1}} |
Calendar year returns (%)
2024 |
2023 |
2022 |
2021 |
{{snapShot.Return1YrCalendar|customNumber:1}} | {{snapShot.Return2YrCalendar|customNumber:1}} | {{snapShot.Return3YrCalendar|customNumber:1}} | {{snapShot.Return4YrCalendar|customNumber:1}} |
2020 |
2019 |
2018 |
2017 |
{{snapShot.Return5YrCalendar|customNumber:1}} | {{snapShot.Return6YrCalendar|customNumber:1}} | {{snapShot.Return7YrCalendar|customNumber:1}} | {{snapShot.Return8YrCalendar|customNumber:1}} |
Range of returns over five years
(August 1, 2018 - August 31, 2025)
Best return |
Best period end date |
Worst return |
Worst period end date |
11.3% |
March 2025 |
5.0% |
Sept. 2023 |
Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
7.9% |
100.0% |
26 |
0 |
Q2 2025 Fund Commentary
Market commentary
Global equities rose over the second quarter of 2025, helped by a gradual reduction of U.S. tariff policy uncertainty. While many tariffs were placed on a 90-day pause, the new 10% baseline rate fueled economic growth concerns. Monetary policy saw some easing, including interest-rate cuts from the Bank of Canada, the European Central Bank and the Bank of England.
Performance
The Fund’s relative exposure to Brookfield Corp. and BRP Inc. had the most positive impact on performance. Brookfield reported positive first-quarter results, proving resilient to global macroeconomic uncertainty. BRP’s stock partially recovered following a decline caused by the proposed U.S. import tariffs on goods from Canada and Mexico. The company’s products manufactured in Canada and Mexico are USMCA-compliant and therefore not subject to tariffs.
Relative exposure to UnitedHealth Group Inc. and ICON PLC was negative for performance. UnitedHealth Group announced the departure of its Chief Executive Officer and pulled its 2025 earnings forecast. The business faces elevated cost trends and heightened regulatory scrutiny. ICON saw weakness in customer demand and delayed or cancelled vaccine trials, stemming from underlying market challenges.
At the sector level, exposure to consumer discretionary and consumer staples had the most positive impact on performance. Security selection in health care, information technology and financials had a negative impact on performance.
Portfolio activity
The sub-advisor added new holdings in Jacobs Solutions Inc., Premium Brands Holdings Corp. and the Canadian National Railway Co. Jacobs Solutions was added because its end markets have been growing, driven by the need to upgrade and add critical infrastructure globally. Premium Brands was added for its scale, experienced management team and ability to grow its business over the next several years. Canadian National Railway was purchased because investments in capacity and network resilience leave it well positioned to benefit from a cyclical recovery.
Outlook
Historically, companies with strong balance sheets, high returns on capital and competitive advantages have not been much impacted by periods of volatility or fluctuations. The sub-advisor views the companies held in the Fund as resilient businesses capable of enduring challenging economic environments.